Transcatheter intraarterial therapies: rationale and overview
Transcatheter intraarterial therapies have proved valuable in the battle against primary and
secondary hepatic malignancies. The unique aspects of all such therapies are their reduced …
secondary hepatic malignancies. The unique aspects of all such therapies are their reduced …
Radioembolization of liver tumors with yttrium-90 microspheres
H Ahmadzadehfar, HJ Biersack, S Ezziddin - Seminars in nuclear medicine, 2010 - Elsevier
Radioembolization (RE), also termed selective internal radiation therapy (SIRT), has been
gradually introduced to the clinical arsenal of cytoreductive modalities in recent years. There …
gradually introduced to the clinical arsenal of cytoreductive modalities in recent years. There …
Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization
Background & Aims Quality of life (QoL) is an important aspect of any palliative treatment.
However, few data are available from studies comparing how embolotherapy affects QoL for …
However, few data are available from studies comparing how embolotherapy affects QoL for …
Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors
AS Kennedy, P McNeillie, WA Dezarn, C Nutting… - International Journal of …, 2009 - Elsevier
PURPOSE: Radioembolization (RE) using 90Y-microspheres is an effective and safe
treatment for patients with unresectable liver malignancies. Radiation-induced liver disease …
treatment for patients with unresectable liver malignancies. Radiation-induced liver disease …
Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization
Purpose To describe volumetric changes of “radiation lobectomy,” a manifestation of hepatic
parenchymal response to lobar 90 Y microsphere radioembolization. Methods Twenty …
parenchymal response to lobar 90 Y microsphere radioembolization. Methods Twenty …
Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis
MAD Vente, M Wondergem, I van der Tweel… - European …, 2009 - Springer
Abstract Radioembolization with yttrium-90 microspheres (90 Y-RE), either glass-or resin-
based, is increasingly applied in patients with unresectable liver malignancies. Clinical …
based, is increasingly applied in patients with unresectable liver malignancies. Clinical …
Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients
L Bester, B Meteling, N Pocock, N Pavlakis… - Journal of Vascular and …, 2012 - Elsevier
PURPOSE: To retrospectively evaluate the safety and survival of patients with chemotherapy-
refractory liver metastases treated with yttrium-90 (90Y) resin microspheres, and to compare …
refractory liver metastases treated with yttrium-90 (90Y) resin microspheres, and to compare …
Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry
AKT Tong, YH Kao, CW Too, KFW Chin… - The British Journal of …, 2016 - academic.oup.com
In recent years, yttrium-90 (90Y) microsphere radioembolization has been establishing itself
as a safe and efficacious treatment for both primary and metastatic liver cancers. This …
as a safe and efficacious treatment for both primary and metastatic liver cancers. This …
Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol
M Albert, MV Kiefer, W Sun, D Haller, DL Fraker… - Cancer, 2011 - Wiley Online Library
BACKGROUND: Unresectable colorectal liver metastases have a 1‐and 2‐year survival of
55% and 33% with current systemic therapies. The authors evaluated response and survival …
55% and 33% with current systemic therapies. The authors evaluated response and survival …
The efficacy of hepatic 90Y resin radioembolization for metastatic neuroendocrine tumors: a meta-analysis
Z Devcic, J Rosenberg, AJA Braat… - Journal of Nuclear …, 2014 - Soc Nuclear Med
90Y resin radioembolization is an emerging treatment in patients with liver-dominant
metastatic neuroendocrine tumors (mNETs), despite the absence of level I data. The aim of …
metastatic neuroendocrine tumors (mNETs), despite the absence of level I data. The aim of …